# A Trial to Learn What Happens to Different Medicinal Forms of BAY2328065 When They Enter the Body and How Safe They Are in Healthy Male and Female Participants

> **NCT04851483** · PHASE1 · COMPLETED · sponsor: **Bayer** · enrollment: 31 (actual)

## Conditions studied

- Endometriosis

## Interventions

- **DRUG:** BAY2328065
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04851483
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-28
- **Primary completion:** 2021-12-14
- **Final completion:** 2022-02-14
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2022-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04851483

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04851483, "A Trial to Learn What Happens to Different Medicinal Forms of BAY2328065 When They Enter the Body and How Safe They Are in Healthy Male and Female Participants". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04851483. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*